DEA Questions FDAs Reccomendation to Reschedule Cannabis Due To a Lack of Therapeutic Evidence SMH

Enjoyed this video? Join my Locals community for exclusive content at thcnterpz.locals.com!
Streamed on:
15
News Education

THCnterpz.locals.com
$bloodshotKoala

yes the DEA whom has worked hand in hand with The FDA for the past 60 years since the controlled substances act have been diverting the study of cannabis to intentionally sub par grown weed. Specifically once a researcher got through the hoops, they were directed the the university of Mississippi more often than not to conduct studies. studies that were conducted regarding the therapeutic applications of cannabis couldn't be ran appropriately as the cannabis was so poor quality there was no difference to be evidenced between the control and the placebo. . . because the weed was intentionally sub par. . . . which I absolutely believe was intentional to keep us from TRUELY seeing what cannabis can do. The FDA had no problem using illicit product to make Epidiolex.
Citrus Tsunami Live Resin
bobbaFet Herb
Advoc8 always
Meduc8 Daily

Don't break the law while your breaking the law.

Loading comments...